India, June 26 -- A major new study published in the Journal of Affective Disorders finds that homework can support learning - but only up to a very clear limit. Beyond that point, it begins to harm s... Read More
India, June 26 -- Larimar Therapeutics, Inc. (LRMR), a clinical-stage biotechnology company focused on rare diseases, announced it will host an investor event to provide updates on its Nomlabofusp pro... Read More
India, June 26 -- Replimmune Group Inc. (REPL), a clinical-stage biotechnology company, on Friday announced the FDA acceptance of the biological license application (BLA) for RP-1 in combination with ... Read More
India, June 26 -- Lupin Limited (LUPIN) has received tentative approval from the U.S. FDA for its generic Enzalutamide Tablets, marking another step in the company's effort to expand its oncology port... Read More
India, June 26 -- Viridian Therapeutics, Inc. (VRDN) announced that the U.S. FDA has approved Lumvoa for the treatment of thyroid eye disease, marking the company's first commercial product and a majo... Read More
India, June 26 -- Medicenna Therapeutics Corp. (MDNAF) reported a wider loss for the financial year ended March 31, 2026, and provided updates on its anticipated clinical milestones. Company Profile ... Read More
India, June 26 -- HCW Biologics Inc. (HCWB) announced a 1-for-6 reverse stock split that will take effect before markets open on June 30, 2026. The move is designed to help the company maintain its li... Read More
India, June 26 -- Revised data released by the University of Michigan on Friday showed consumer sentiment in the U.S. rebounded by slightly more than previously estimated in the month of June. The Un... Read More
India, June 26 -- Universe Pharmaceuticals Inc (UPC), a pharmaceutical producer and distributor in China, has entered into a share purchase agreement to acquire Best Praise International Limited, a co... Read More
India, June 26 -- Doma Perpetual Capital Management LLC issued a letter to the InMode Ltd.(INMD) Board on Friday, expressing its strong opposition to an acquisition proposal from the Chief Executive O... Read More